Searched over 200M research papers
10 papers analyzed
These studies suggest insulin is used primarily for managing diabetes by controlling blood glucose levels, improving glycemic control, and reducing complications, with additional potential uses in treating mild cognitive impairment and Alzheimer's disease.
20 papers analyzed
Insulin is a life-saving treatment for individuals with type 1 diabetes, a condition where the body cannot produce insulin naturally. This hormone is essential for regulating blood glucose levels, and without it, patients would experience severe hyperglycemia and other life-threatening complications.
In type 2 diabetes, insulin is often used when other treatments fail to maintain adequate blood glucose control. It is typically introduced later in the disease progression but can be used earlier to improve long-term glycemic control and correct underlying pathophysiological abnormalities . Newer insulin analogs, such as long-acting and rapid-acting insulins, offer more flexibility and better mimic the body's natural insulin release, reducing the risk of hypoglycemia and weight gain .
Traditional insulin delivery involves subcutaneous injections, which can be invasive and affect patient compliance. Innovations in delivery methods, such as insulin pens, pumps, and even transdermal systems, aim to improve ease of use and patient adherence . Oral and inhaled insulin are also being developed to provide non-invasive alternatives .
Recent studies have explored the use of intranasal insulin to treat mild cognitive impairment and Alzheimer's disease. Insulin can modulate brain functions relevant to these conditions. However, a recent clinical trial found no significant cognitive or functional benefits from intranasal insulin treatment over a 12-month period.
Insulin is a polypeptide hormone secreted by the pancreas that plays a crucial role in regulating blood glucose levels. It promotes glucose uptake and storage in the liver, muscles, and adipose tissue, working in concert with glucagon, which has opposing effects.
Insulin's anabolic effects extend beyond glucose regulation. It influences various metabolic processes, including protein synthesis and lipid metabolism. This broad range of actions makes insulin critical in the onset and progression of several chronic diseases.
Advances in peptide chemistry and recombinant DNA technology have led to the creation of insulin analogs that offer improved pharmacokinetic and pharmacodynamic profiles. These analogs help achieve better glucose control with fewer side effects, such as hypoglycemia and weight gain .
The ultimate goal in insulin therapy is to develop formulations that respond dynamically to blood glucose levels, mimicking the body's natural insulin release. Initial prototypes of such glucose-responsive insulins are currently in the proof-of-concept stage. Additionally, ongoing research into transdermal delivery systems holds promise for more user-friendly insulin administration methods.
Insulin remains a cornerstone in the treatment of diabetes, with expanding roles in other medical conditions such as cognitive impairment. Continuous advancements in insulin formulations and delivery methods aim to improve patient outcomes and quality of life. As research progresses, the future of insulin therapy looks promising, with the potential for more effective and convenient treatment options.
Most relevant research papers on this topic